22nd Century Urges FDA to Finalize Long-Pending Reduced Nicotine Rule
Event summary
- 22nd Century Group calls on FDA to finalize the Reduced Nicotine Content Standard, pending since 2025 after a 2018 advance notice.
- The proposed rule aims to cap nicotine levels in cigarettes and other combusted tobacco products at 0.70 mg/g to reduce addiction.
- FDA's own analysis projects the rule could prevent 48 million youth from starting to smoke and avert 1.8 million tobacco-related deaths by 2060.
- 22nd Century's VLN® cigarettes are the only FDA-authorized low nicotine combustible cigarettes in the U.S.
- The company urges Congress to demand a timeline for the rule's implementation, citing the Tobacco Control Act of 2009's 180-day review framework.
The big picture
22nd Century's push for the Reduced Nicotine Content Standard comes amid broader regulatory shifts in tobacco control, including accelerated authorizations for lower-risk alternatives. The company positions the rule as a critical component of a continuum-of-risk strategy, aiming to reduce harm for both youth and adult smokers. The FDA's delay in finalizing the rule, despite its projected significant public health benefits, highlights the regulatory hurdles in tobacco harm reduction.
What we're watching
- Regulatory Timing
- Whether the FDA will accelerate the finalization of the Reduced Nicotine Content Standard in response to 22nd Century's advocacy.
- Policy Coordination
- How the Trump administration's reported acceleration of vape and nicotine pouch authorizations will interact with the proposed nicotine reduction rule.
- Market Impact
- The pace at which retailers will allocate shelf space for very low nicotine content (VLNC) products if the rule is implemented.